• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

玻璃体脂质组学与代谢组学整合以全面理解增殖性糖尿病视网膜病变的发病机制

Integration of Vitreous Lipidomics and Metabolomics for Comprehensive Understanding of the Pathogenesis of Proliferative Diabetic Retinopathy.

作者信息

Fang Junwei, Wang Hanying, Niu Tian, Shi Xin, Xing Xindan, Qu Yuan, Liu Yujuan, Liu Xinyi, Xiao Yu, Dou Tianyu, Shen Yinchen, Liu Kun

机构信息

Department of Ophthalmology, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200080, China.

National Clinical Research Center for Eye Diseases, Shanghai 200080, China.

出版信息

J Proteome Res. 2023 Jul 7;22(7):2293-2306. doi: 10.1021/acs.jproteome.3c00007. Epub 2023 Jun 17.

DOI:10.1021/acs.jproteome.3c00007
PMID:37329324
Abstract

As a vision-threatening complication of diabetes mellitus (DM), proliferative diabetic retinopathy (PDR) is associated with sustained metabolic disorders. Herein, we collected the vitreous cavity fluid of 49 patients with PDR and 23 control subjects without DM for metabolomics and lipidomics analyses. Multivariate statistical methods were performed to explore relationships between samples. For each group of metabolites, gene set variation analysis scores were generated, and we constructed a lipid network by using weighted gene co-expression network analysis. The association between lipid co-expression modules and metabolite set scores was investigated using the two-way orthogonal partial least squares (O2PLS) model. A total of 390 lipids and 314 metabolites were identified. Multivariate statistical analysis revealed significant vitreous metabolic and lipid differences between PDR and controls. Pathway analysis showed that 8 metabolic processes might be associated with the development of PDR, and 14 lipid species were found to be altered in PDR patients. Combining metabolomics and lipidomics, we identified fatty acid desaturase 2 (FADS2) as an important potential contributor to the pathogenesis of PDR. Collectively, this study integrates vitreous metabolomics and lipidomics to comprehensively unravel metabolic dysregulation and identifies genetic variants associated with altered lipid species in the mechanistic pathways for PDR.

摘要

作为糖尿病(DM)的一种威胁视力的并发症,增殖性糖尿病视网膜病变(PDR)与持续的代谢紊乱有关。在此,我们收集了49例PDR患者和23例无DM的对照受试者的玻璃体腔液,进行代谢组学和脂质组学分析。采用多元统计方法探讨样本之间的关系。对于每组代谢物,生成基因集变异分析得分,并使用加权基因共表达网络分析构建脂质网络。使用双向正交偏最小二乘法(O2PLS)模型研究脂质共表达模块与代谢物集得分之间的关联。共鉴定出390种脂质和314种代谢物。多元统计分析显示PDR患者与对照组之间玻璃体代谢和脂质存在显著差异。通路分析表明,8种代谢过程可能与PDR的发生发展有关,并且发现14种脂质在PDR患者中发生了改变。结合代谢组学和脂质组学,我们确定脂肪酸去饱和酶2(FADS2)是PDR发病机制的一个重要潜在因素。总体而言,本研究整合了玻璃体代谢组学和脂质组学,以全面揭示代谢失调,并在PDR的机制途径中鉴定与脂质种类改变相关的基因变异。

相似文献

1
Integration of Vitreous Lipidomics and Metabolomics for Comprehensive Understanding of the Pathogenesis of Proliferative Diabetic Retinopathy.玻璃体脂质组学与代谢组学整合以全面理解增殖性糖尿病视网膜病变的发病机制
J Proteome Res. 2023 Jul 7;22(7):2293-2306. doi: 10.1021/acs.jproteome.3c00007. Epub 2023 Jun 17.
2
Vitreous metabolomics profiling of proliferative diabetic retinopathy.增生型糖尿病视网膜病变的玻璃体代谢组学分析。
Diabetologia. 2021 Jan;64(1):70-82. doi: 10.1007/s00125-020-05309-y. Epub 2020 Oct 25.
3
Altered oxylipin levels in human vitreous indicate imbalance in pro-/anti-inflammatory homeostasis in proliferative diabetic retinopathy.人眼玻璃体中氧化脂水平的改变表明增殖性糖尿病性视网膜病变中促炎/抗炎内稳态失衡。
Exp Eye Res. 2022 Jan;214:108799. doi: 10.1016/j.exer.2021.108799. Epub 2021 Oct 21.
4
Plasma and Vitreous Metabolomics Profiling of Proliferative Diabetic Retinopathy.增生型糖尿病视网膜病变的血浆和玻璃体代谢组学分析。
Invest Ophthalmol Vis Sci. 2022 Feb 1;63(2):17. doi: 10.1167/iovs.63.2.17.
5
Metabolic fingerprints of proliferative diabetic retinopathy: an 1H-NMR-based metabonomic approach using vitreous humor.增生型糖尿病性视网膜病变的代谢指纹:一种基于 1H-NMR 的代谢组学方法,使用玻璃体。
Invest Ophthalmol Vis Sci. 2010 Sep;51(9):4416-21. doi: 10.1167/iovs.10-5348. Epub 2010 Apr 7.
6
Untargeted Multiomics Approach Coupling Lipidomics and Metabolomics Profiling Reveals New Insights in Diabetic Retinopathy.非靶向多组学方法结合脂质组学和代谢组学分析揭示糖尿病视网膜病变的新见解。
Int J Mol Sci. 2023 Jul 27;24(15):12053. doi: 10.3390/ijms241512053.
7
[New exploration of treatment target for proliferative diabetic retinopathy based on iTRAQ LC-MS/MS Proteomics].基于iTRAQ液相色谱-串联质谱蛋白质组学的增殖性糖尿病视网膜病变治疗靶点新探索
Zhonghua Yan Ke Za Zhi. 2019 Oct 11;55(10):769-776. doi: 10.3760/cma.j.issn.0412-4081.2019.10.008.
8
Unique molecular signatures of microRNAs in ocular fluids and plasma in diabetic retinopathy.糖尿病视网膜病变患者眼内液和血浆中微小RNA的独特分子特征
PLoS One. 2020 Jul 21;15(7):e0235541. doi: 10.1371/journal.pone.0235541. eCollection 2020.
9
Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy.无糖尿病视网膜病变的糖尿病患者和增殖性糖尿病视网膜病变的糖尿病患者玻璃体液蛋白质组的特征分析
J Proteome Res. 2008 Jun;7(6):2516-25. doi: 10.1021/pr800112g. Epub 2008 Apr 24.
10
Deranged Metabolic Profile and Identification of Biomarkers in the Vitreous Humour of Patients with Proliferative Diabetic Retinopathy.增殖性糖尿病视网膜病变患者玻璃体液中代谢谱紊乱及生物标志物的鉴定
Protein Pept Lett. 2018;25(8):791-798. doi: 10.2174/0929866525666180821120548.

引用本文的文献

1
Metabolomic insights into vitreous humor with therapy outcome in type 2 diabetic retinopathy.2型糖尿病视网膜病变玻璃体的代谢组学见解与治疗结果
BMC Ophthalmol. 2025 Aug 15;25(1):460. doi: 10.1186/s12886-025-04283-6.
2
Multi-omics characterization of diabetic nephropathy in the db/db mouse model of type 2 diabetes.2型糖尿病db/db小鼠模型中糖尿病肾病的多组学特征分析
Comput Struct Biotechnol J. 2025 Jul 23;27:3399-3409. doi: 10.1016/j.csbj.2025.07.037. eCollection 2025.
3
Novel High-Resolution Lipidomes Could Serve as New Biomarkers for Diabetic Retinopathy: A Bidirectional and Mediated Mendelian Randomization Study.
新型高分辨率脂质组可作为糖尿病视网膜病变的新生物标志物:一项双向中介孟德尔随机化研究。
J Cell Mol Med. 2025 Jun;29(11):e70614. doi: 10.1111/jcmm.70614.
4
Metabolomics of ocular immune diseases.眼部免疫疾病的代谢组学
Metabolomics. 2025 Jun 2;21(3):74. doi: 10.1007/s11306-025-02273-9.
5
High BMI, silicone oil tamponade, and recurrent vitreous hemorrhage predict poor visual outcomes after pars plana vitrectomy in proliferative diabetic retinopathy.高体重指数、硅油填充和复发性玻璃体出血预示着增殖性糖尿病视网膜病变行玻璃体切割术后视力预后较差。
BMC Ophthalmol. 2025 Mar 19;25(1):148. doi: 10.1186/s12886-025-03954-8.
6
Spatial characterization of RPE structure and lipids in the PEX1-p.Gly844Asp mouse model for Zellweger spectrum disorder.针对齐-韦氏综合征谱障碍的PEX1-p.Gly844Asp小鼠模型中视网膜色素上皮(RPE)结构和脂质的空间特征分析
J Lipid Res. 2025 Apr;66(4):100771. doi: 10.1016/j.jlr.2025.100771. Epub 2025 Mar 7.
7
Causal effect of immune cells, metabolites, cathepsins, and vitamin therapy in diabetic retinopathy: a Mendelian randomization and cross-sectional study.免疫细胞、代谢物、组织蛋白酶和维生素治疗在糖尿病视网膜病变中的因果作用:孟德尔随机化和横断面研究。
Front Immunol. 2024 Oct 1;15:1443236. doi: 10.3389/fimmu.2024.1443236. eCollection 2024.
8
Comparative Proteomic Analysis of Type 2 Diabetic versus Non-Diabetic Vitreous Fluids.2型糖尿病与非糖尿病玻璃体液的比较蛋白质组学分析
Life (Basel). 2024 Jul 16;14(7):883. doi: 10.3390/life14070883.
9
Causal relationships between blood metabolites and diabetic retinopathy: a two-sample Mendelian randomization study.血液代谢物与糖尿病视网膜病变之间的因果关系:两样本孟德尔随机化研究。
Front Endocrinol (Lausanne). 2024 May 1;15:1383035. doi: 10.3389/fendo.2024.1383035. eCollection 2024.
10
Critical Factors in Sample Collection and Preparation for Clinical Metabolomics of Underexplored Biological Specimens.未充分探索的生物样本临床代谢组学样本采集与制备中的关键因素
Metabolites. 2024 Jan 5;14(1):36. doi: 10.3390/metabo14010036.